47MO Metabolic intervention during CAR T-cell manufacturing improves persistence and antitumor efficacy
Mathias Wenes(University of Geneva), Pedro Romero(Ludwig Cancer Research), Noelia Maldonado‐Pérez(Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research), L. Zhang(Suzhou Institute of Systems Medicine), S-T. Teoh(Michigan State University), Sophia Y. Lunt(Michigan State University), Benjamin Tschumi(University of Lausanne), Alena Donda(University of Lausanne), Fabien Franco(Ludwig Cancer Research), Alison Jaccard(Cancer Research Institute of the Slovak Academy of Sciences), Patrice Waridel(University of Lausanne), Tania Wyss(University of Lausanne), Denis Migliorini(University of Geneva), F. Martín(Universidad de Granada), Florence Renaud(University of Lausanne), P-C. Ho(Ludwig Cancer Research), Anouk Lepez(Swiss Cancer Center Léman)
Cited by 0
Related Papers
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
|Science|1996|1.3k
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
|Science|2007|1.1k
A roadmap for interpreting 13C metabolite labeling patterns from cells
|Current Opinion in Biotechnology|2015|652
Metabolic and epigenetic regulation of T-cell exhaustion
|Nature Metabolism|2020|443
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
|Nature Immunology|2021|422